News and Announcements
Second Patient In Human Cancer Trial Begins Treatment
- Published November 24, 2014 2:54PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Source: ASX; Published: 24 November 2014
PharmAust Limited (ASX:PAA & PAA)) is pleased to report that it has initiated treatment of the second patient on 21 November 2014 in its ‘First in Man’ trial with PPL-1. To date the drug appears safe and no adverse events have been observed. The patient will receive PPL-1 daily for 28 days. The patient is suffering from lung cancer with metastases to other organs.
PharmAust’s Executive Chairmna Dr Roger Aston said “In addition to the second patient referred above, a further two patients have entered screening and, subject to their suitability, will be recruited and also begin treatment on 2 and 9 December respectively’.
Please download the document below to view the full announcement.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
